Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:39 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
NCT01408641 · University of Maryland, Baltimore · NA · terminated · last registry update 2022-03-03 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Principal Investigator was deployed overseas” | – | Registry record, University of Maryland, Baltimore |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CA2 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2023-03-01Results posted on the registry: The University of Texas Health Science Center, Houston, Acetazolamide + Placebo (NCT02466074)
- 2023-02-28Phase 3 first posted: AbbVie, Atogepant + Placebo for Atogepant (NCT05748483)
- 2023-02-15Results posted on the registry: CrystalGenomics, Inc., CG100649 + Celecoxib (NCT01765296)
- 2023-02-14Also stopped (terminated): Hartford Hospital, Administration of weight loss drug (Metformin or Topiramate) (NCT03603080)
- 2023-02-09Results posted on the registry: CrystalGenomics, Inc., CG100649 + Celecoxib (NCT01341405)
- 2023-02-01Phase 3 first posted: Beijing Tiantan Hospital, Acetazolamide-based medical therapy (NCT05707442)
- 2022-10-04Also stopped (withdrawn): University of the Incarnate Word, Dorzolamide Hcl 2% Oph Soln (NCT04676126)
- 2022-09-10Results posted on the registry: VIVUS LLC, VI-0521 oral capsule + Placebo oral capsule (NCT03922945)
- 2022-07-13Results posted on the registry: University of Colorado, Denver, Topiramate (NCT03335163)
- 2022-06-27Also stopped (withdrawn): Assistance Publique Hopitaux De Marseille, Perampanel + conventional antiepileptic treatment (NCT03636958)
- 2022-06-16Results posted on the registry: Jaeb Center for Health Research, Acetazolamide (NCT03501966)
- 2022-06-16Also stopped (terminated): Jaeb Center for Health Research, Acetazolamide (NCT03501966)
- 2022-03-02Phase 3 first posted: University of Southern Denmark, Rapid sedation (NCT05263674)
- 2022-01-27Phase 3 first posted: Eurofarma Laboratorios S.A., ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg + ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg (NCT05209984)
- 2021-12-14Also stopped (withdrawn): University of Miami, Acetazolamide (NCT04351061)
- 2021-10-19Phase 3 first posted: Shahid Beheshti University of Medical Sciences, Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide + Injections of 1.25 mg of intravitreal bevacizumab with artificial tears (NCT05083689)
- 2021-10-15Results posted on the registry: University of Illinois Chicago, 2% dorzolamide (NCT00716586)
- 2021-08-26Phase 3 first posted: Sun Pharmaceutical Industries Limited, Brinzolamide ophthalmic suspension + Azopt® (NCT05022004)
- 2021-08-09Results posted on the registry: Novartis Pharmaceuticals, Erenumab + Topiramate (NCT03828539)
- 2021-06-29Phase 3 first posted: Padagis LLC, Brinzolamide/brimonidine ophthalmic suspension + Simbrinza 0.2%/1% Ophthalmic Suspension (NCT04944290)
- 2021-06-21Results posted on the registry: University of California, San Francisco, Topiramate + placebo (NCT01749215)
- 2021-06-18Results posted on the registry: Novo Nordisk A/S, Medication for chronic weight management (Rx) (NCT03799198)
- 2021-06-09Results posted on the registry: University of Iowa, Metformin + Orlistat (NCT01351753)
- 2021-06-09Results posted on the registry: Bausch & Lomb Incorporated, brinzolamide 1% ophthalmic suspension + Azopt 1% (NCT01722604)
- 2021-06-09Results posted on the registry: Bausch & Lomb Incorporated, brinzolamide 1% ophthalmic suspension + Azopt 1% (NCT03896633)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision